Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCOA1 | Q15788 | 1/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.47 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11683049 | 1.00 | NCOA1 (0.56) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL74839 | 0.89 | ALDH1A1 (0.52) | NCOA1NCOA3ALDH1A1TSHRKMT2A | |
| SCHEMBL3843172 | 0.87 | ALDH1A1 (0.50) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL1270920 | 0.84 | MAOA (0.68) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL459355 | 0.84 | MAOA (0.68) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL29476109 | 0.84 | MAOA (0.68) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL3845666 | 0.83 | SLC6A4 (0.53) | NCOA1NCOA3MAPTALDH1A1TDP1 | |
| SCHEMBL8954758 | 0.83 | LTA4H (0.55) | NCOA1NCOA3MAOAALDH1A1TSHR | |
| SCHEMBL6290540 | 0.82 | MAOA (0.73) | NCOA1NCOA3MAOAMAPTALDH1A1 | |
| SCHEMBL6290292 | 0.82 | MAOA (0.65) | NCOA1NCOA3MAOAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220378923-A1 | BET DEGRADER | KYOWA KIRIN CO., LTD. (JP) | 2022-12-01 | — | — | US | disclosed |
| EP-4039333-A1 | BET DEGRADER | Kyowa Kirin Co., Ltd. (JP) | 2022-08-10 | — | — | EP | disclosed |
| CN-114502534-A | BET degradant | 协和麒麟株式会社 | 2022-05-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220378923-A1 | BET DEGRADER | BET1, BRD4, BICRA | NCOA1 128/4885NCOA3 455/4885MAOA 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.